GNLX
GENELUX Corp
+0.14 (+5.98%)2.48USD125K成交股數112M市值–本益比(近四季)14026.0股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 7 · 194K · 4 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 252K |
| 近 180 天 淨額 | −252K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 | 09-02 | Zindrick Thomas | President and CEO | S 公開市場賣出 | 34.5K | 2.67 | 92K | 1.2M | SEC |
| 2026-08-31 | 09-02 | Cappello Joseph | Chief Technical Officer | S 公開市場賣出 | 10.3K | 2.74 | 28K | 318K | SEC |
| 2026-08-31 | 09-02 | Yu Yong | Chief Scientific Officer | S 公開市場賣出 | 9.7K | 2.75 | 27K | 259K | SEC |
| 2026-08-04 | 08-04 | Cappello Joseph | Chief Technical Officer | S 公開市場賣出 | 653 | 2.95 | 2K | 329K | SEC |
| 2026-08-04 | 08-04 | Zindrick Thomas | President and CEO | S 公開市場賣出 | 3.0K | 2.95 | 9K | 1.3M | SEC |
| 2026-08-04 | 08-04 | Yu Yong | Chief Scientific Officer | S 公開市場賣出 | 653 | 2.94 | 2K | 268K | SEC |
| 2026-07-01 | 07-02 | Smither John W | Director | S 公開市場賣出 | 12.0K | 2.91 | 35K | 91.4K | SEC |
| 2026-06-16 | 06-18 | Yu Yong | Chief Scientific Officer | A 獲配股票 | 119K | – | – | 269K | SEC |
| 2026-06-16 | 06-18 | Cappello Joseph | Chief Technical Officer | A 獲配股票 | 175K | – | – | 329K | SEC |
| 2026-06-16 | 06-18 | Tyree James L | Director | A 獲配股票 | 28.4K | – | – | 96.5K | SEC |
| 2026-06-16 | 06-18 | Mirabelli Mary | Director | A 獲配股票 | 28.4K | – | – | 103K | SEC |
| 2026-06-16 | 06-18 | Thomas John | Director | A 獲配股票 | 28.4K | – | – | 501K | SEC |
| 2026-06-16 | 06-18 | Smither John W | Director | A 獲配股票 | 28.4K | – | – | 103K | SEC |
| 2026-06-16 | 06-18 | Zindrick Thomas | President and CEO | A 獲配股票 | 731K | – | – | 1.3M | SEC |
| 2026-06-16 | 06-18 | Groen Eric | General Counsel | A 獲配股票 | 234K | – | – | 234K | SEC |
| 2026-06-16 | 06-18 | Pulisic Matthew | Chief Financial Officer | A 獲配股票 | 279K | – | – | 279K | SEC |
| 2026-06-03 | 06-04 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 192 | 2.93 | 562.56 | 67.6K | SEC |
| 2026-06-01 | 06-02 | Thomas John | Director | S 公開市場賣出(10b5-1) | 10.0K | 2.98 | 30K | 473K | SEC |
| 2026-05-11 | 05-12 | Cappello Joseph | Chief Technical Officer | S 公開市場賣出 | 605 | 2.97 | 2K | 155K | SEC |
| 2026-05-11 | 05-12 | Yu Yong | Chief Scientific Officer | S 公開市場賣出 | 605 | 2.97 | 2K | 150K | SEC |
| 2026-05-11 | 05-12 | Zindrick Thomas | President and CEO | S 公開市場賣出 | 2.8K | 2.94 | 8K | 532K | SEC |
| 2026-05-11 | 05-12 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 270 | 2.98 | 804.60 | 67.8K | SEC |
| 2026-03-25 | 03-26 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 240 | 2.51 | 602.40 | 68.1K | SEC |
| 2026-03-24 | 03-26 | Zindrick Thomas | President and CEO | S 公開市場賣出 | 3.6K | 2.42 | 9K | 535K | SEC |
| 2026-03-24 | 03-26 | Yu Yong | SVP, Clinical Development | S 公開市場賣出 | 906 | 2.42 | 2K | 145K | SEC |
| 2026-03-24 | 03-26 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 345 | 2.42 | 834.90 | 68.3K | SEC |
| 2026-03-24 | 03-26 | Cappello Joseph | Chief Technical Officer | S 公開市場賣出 | 906 | 2.42 | 2K | 155K | SEC |
| 2026-03-02 | 03-03 | Thomas John | Director | S 公開市場賣出(10b5-1) | 10.0K | 2.90 | 29K | 483K | SEC |
| 2025-12-05 | 12-09 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 165 | 4.69 | 773.85 | 68.7K | SEC |
| 2025-12-01 | 12-02 | Thomas John | Director | S 公開市場賣出(10b5-1) | 10.0K | 5.00 | 50K | 493K | SEC |
| 2025-11-17 | 12-11 | Cappello Joseph | Chief Technical Officer | S 公開市場賣出 | 973 | 5.37 | 5K | 156K | SEC |
| 2025-11-17 | 12-11 | Zindrick Thomas | President and CEO | S 公開市場賣出 | 4.5K | 5.37 | 24K | 538K | SEC |
| 2025-11-17 | 12-11 | Yu Yong | SVP, Clinical Development | S 公開市場賣出 | 973 | 5.37 | 5K | 146K | SEC |
| 2025-11-17 | 12-09 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 343 | 5.37 | 2K | 68.8K | SEC |
| 2025-09-03 | 12-09 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 580 | 3.36 | 2K | 69.2K | SEC |
| 2025-09-01 | 09-03 | Smalling Ralph | Head of Regulatory | A 獲配股票 | 10.0K | – | – | 71.0K | SEC |
| 2025-08-27 | 08-29 | Smither John W | Director | A 獲配股票 | 22.3K | – | – | 75.0K | SEC |
| 2025-08-27 | 08-29 | Tyree James L | Director | A 獲配股票 | 22.3K | – | – | 68.1K | SEC |
| 2025-08-27 | 08-29 | Thomas John | Director | A 獲配股票 | 22.3K | – | – | 503K | SEC |
| 2025-08-27 | 08-29 | Zindrick Thomas | President and CEO | A 獲配股票 | 361K | – | – | 554K | SEC |
| 2025-08-27 | 08-29 | Yu Yong | SVP, Clinical Development | A 獲配股票 | 101K | – | – | 150K | SEC |
| 2025-08-27 | 08-29 | Smalling Ralph | Head of Regulatory | A 獲配股票 | 26.2K | – | – | 61.0K | SEC |
| 2025-08-27 | 08-29 | Cappello Joseph | Chief Technical Officer | A 獲配股票 | 108K | – | – | 160K | SEC |
| 2025-08-27 | 08-29 | Mirabelli Mary | Director | A 獲配股票 | 22.3K | – | – | 73.3K | SEC |
| 2025-08-21 | 12-11 | Cappello Joseph | Chief Technical Officer | S 公開市場賣出 | 1.5K | 3.36 | 5K | 157K | SEC |
| 2025-08-21 | 12-11 | Zindrick Thomas | President and CEO | S 公開市場賣出 | 12.7K | 3.33 | 42K | 543K | SEC |
| 2025-08-21 | 12-11 | Yu Yong | SVP, Clinical Development | S 公開市場賣出 | 3.2K | 3.36 | 11K | 147K | SEC |
| 2025-08-21 | 12-11 | Cappello Joseph | Chief Technical Officer | S 公開市場賣出 | 1.3K | 3.33 | 4K | 158K | SEC |
| 2025-08-21 | 12-09 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 1.2K | 3.36 | 4K | 69.7K | SEC |
| 2025-06-06 | 06-24 | Thomas John | Director | G 贈與 | 25.0K | – | – | 481K | SEC |
| 2025-05-12 | 05-13 | Cappello Joseph | VP, Pharmaceutical Development | S 公開市場賣出 | 4.7K | 2.92 | 14K | 52.3K | SEC |
| 2025-05-12 | 05-13 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 1.3K | 2.92 | 4K | 34.8K | SEC |
| 2025-05-12 | 05-13 | Ryder Sean | General Counsel | S 公開市場賣出 | 4.5K | 2.92 | 13K | 47.6K | SEC |
| 2025-05-12 | 05-13 | Zindrick Thomas | President and CEO | S 公開市場賣出 | 10.8K | 2.92 | 31K | 191K | SEC |
| 2025-05-12 | 05-13 | Yu Yong | VP, Clinical Trial Operations | S 公開市場賣出 | 5.6K | 2.92 | 16K | 47.6K | SEC |
| 2025-03-14 | 04-17 | Ryder Sean | General Counsel | A 獲配股票 | 10.7K | – | – | 52.1K | SEC |
| 2025-03-14 | 04-17 | Smalling Ralph | Head of Regulatory | A 獲配股票 | 4.2K | – | – | 36.0K | SEC |
| 2025-03-14 | 04-17 | Zindrick Thomas | President and CEO | A 獲配股票 | 30.3K | – | – | 202K | SEC |
| 2025-03-14 | 04-17 | Cappello Joseph | VP, Pharmaceutical Development | A 獲配股票 | 13.3K | – | – | 57.0K | SEC |
| 2025-03-14 | 04-17 | Yu Yong | VP, Clinical Trial Operations | A 獲配股票 | 13.3K | – | – | 53.2K | SEC |
| 2024-12-30 | 12-30 | Tyree James L | Director | S 公開市場賣出 | 3.5K | 2.46 | 9K | 45.8K | SEC |
| 2024-12-18 | 12-20 | Zak Lourie S. | Chief Financial Officer | A 獲配股票 | 41.6K | – | – | 82.5K | SEC |
| 2024-12-18 | 12-20 | Yu Yong | VP, Clinical Trial Operations | A 獲配股票 | 29.0K | – | – | 39.9K | SEC |
| 2024-12-18 | 12-20 | Cappello Joseph | VP, Pharmaceutical Development | A 獲配股票 | 29.0K | – | – | 43.7K | SEC |
| 2024-12-18 | 12-20 | Ryder Sean | General Counsel | A 獲配股票 | 22.0K | – | – | 41.4K | SEC |
| 2024-12-18 | 12-20 | Zindrick Thomas | President and CEO | A 獲配股票 | 135K | – | – | 172K | SEC |
| 2024-12-18 | 12-20 | Smalling Ralph | Head of Regulatory | A 獲配股票 | 15.5K | – | – | 31.8K | SEC |
| 2024-12-16 | 12-18 | Smalling Ralph | Head of Regulatory | S 公開市場賣出 | 2.5K | 2.34 | 6K | 16.3K | SEC |
| 2024-12-16 | 12-18 | Cappello Joseph | VP, Pharmaceutical Development | S 公開市場賣出 | 6.3K | 2.34 | 15K | 14.7K | SEC |
| 2024-12-16 | 12-18 | Zak Lourie S. | Chief Financial Officer | S 公開市場賣出 | 2.1K | 2.34 | 5K | 40.8K | SEC |
| 2024-12-16 | 12-18 | Zindrick Thomas | President and CEO | S 公開市場賣出 | 14.3K | 2.34 | 33K | 37.4K | SEC |
| 2024-09-13 | 09-13 | Szalay Aladar | TenPercentOwner | S 公開市場賣出 | 33.1K | 2.57 | 85K | 600K | SEC |
| 2024-09-12 | 09-13 | Szalay Aladar | TenPercentOwner | S 公開市場賣出 | 31.8K | 2.73 | 87K | 633K | SEC |
| 2024-09-11 | 09-12 | Tyree James L | Director | S 公開市場賣出(10b5-1) | 1.7K | 2.60 | 4K | 47.5K | SEC |
| 2024-09-11 | 09-11 | Szalay Aladar | TenPercentOwner | S 公開市場賣出 | 31.4K | 2.62 | 82K | 665K | SEC |
| 2024-09-10 | 09-11 | Szalay Aladar | TenPercentOwner | S 公開市場賣出 | 20.4K | 2.51 | 51K | 696K | SEC |
| 2024-09-09 | 09-11 | Szalay Aladar | TenPercentOwner | S 公開市場賣出 | 23.4K | 2.70 | 63K | 716K | SEC |
| 2024-09-03 | 09-06 | Szalay Aladar | TenPercentOwner | S 公開市場賣出 | 42.8K | 2.09 | 89K | 740K | SEC |
| 2024-08-30 | 08-30 | Szalay Aladar | TenPercentOwner | S 公開市場賣出 | 143K | 2.17 | 309K | 783K | SEC |
| 2024-08-29 | 08-30 | Szalay Aladar | TenPercentOwner | S 公開市場賣出 | 107K | 1.98 | 212K | 925K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | 2.3M | 6.8M | +145K (+7%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | 5.0M | −17.8K (-1%) | 減碼 |
| Bleichroeder LP | 1.4M | 4.2M | 不變 | 持平 |
| BlackRock, Inc. | 440K | 1.3M | +33.7K (+8%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 439K | 1.3M | −14.5K (-3%) | 減碼 |
| CM Management, LLC | 400K | 1.2M | +150K (+60%) | 加碼 |
| BANK OF AMERICA CORP /DE/ | 329K | 990K | +4.9K (+2%) | 加碼 |
| VANGUARD FIDUCIARY TRUST CO | 236K | 711K | −15.3K (-6%) | 減碼 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 231K | 697K | −49.5K (-18%) | 減碼 |
| Global Retirement Partners, LLC | 228K | 686K | 新進 | 新進 |
| LPL Financial LLC | 158K | 475K | +18.8K (+14%) | 加碼 |
| STATE STREET CORP | 146K | 439K | 不變 | 持平 |
| Provident Wealth Management, LLC | 145K | 436K | −10.8K (-7%) | 減碼 |
| LifeSteps Financial, Inc. | 122K | 367K | +3.1K (+3%) | 加碼 |
| OSAIC HOLDINGS, INC. | 122K | 367K | +3.0K (+2%) | 加碼 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 105K | 317K | +93.0K (+763%) | 加碼 |
| NORTHERN TRUST CORP | 89.3K | 269K | −75.2K (-46%) | 減碼 |
| 城堡 CITADEL ADVISORS LLC | 85.5K | 257K | 新進 | 新進 |
| MORGAN STANLEY | 83.5K | 251K | −4.5K (-5%) | 減碼 |
| SteelPeak Wealth, LLC | 75.9K | 228K | +15.0K (+25%) | 加碼 |
| AMG National Trust Bank | 75.4K | 227K | 不變 | 持平 |
| Falcon Wealth Planning | 63.2K | 190K | 不變 | 持平 |
| Mariner, LLC | 52.9K | 159K | +25.0K (+90%) | 加碼 |
| Quadrature Capital Ltd | 45.9K | 138K | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 45.8K | 138K | +13.2K (+40%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 72 +1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 11 / 10 / 18 / 14 |
| 機構合計持股 · 佔流通股 | 9.8M · 21.7% |
| 合計季末市值 | 29.4M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.8M |
|---|---|
| 與上期比 | +7.3% |
| 佔流通股數 | 8.34% |
| 日均成交量 | 355K |
| 回補天數 | 10.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.8M | +7.3% | 8.34% | 355K | 10.7 |
| 2026-08-14 | 3.5M | +14.1% | 7.78% | 416K | 8.5 |
| 2026-07-31 | 3.1M | -1.0% | 6.81% | 153K | 20.2 |
| 2026-07-15 | 3.1M | +3.5% | 6.88% | 174K | 17.9 |
| 2026-06-30 | 3.0M | -5.5% | 6.65% | 235K | 12.8 |
| 2026-06-15 | 3.2M | +1.5% | 7.04% | 152K | 20.9 |
| 2026-05-29 | 3.1M | +6.0% | 6.93% | 131K | 24.0 |
| 2026-05-15 | 3.0M | -6.0% | 6.54% | 196K | 15.1 |
| 2026-04-30 | 3.1M | +4.2% | 6.96% | 130K | 24.3 |
| 2026-04-15 | 3.0M | -3.7% | 6.68% | 288K | 10.5 |
| 2026-03-31 | 3.1M | +9.9% | 6.93% | 209K | 15.0 |
| 2026-03-13 | 2.9M | -3.7% | 6.30% | 152K | 18.8 |
| 2026-02-27 | 3.0M | -4.7% | 6.55% | 126K | 23.5 |
| 2026-02-13 | 3.1M | -1.5% | 6.87% | 227K | 13.7 |
| 2026-01-30 | 3.2M | +3.1% | 6.98% | 237K | 13.3 |
| 2026-01-15 | 3.1M | +1.2% | 6.77% | 534K | 5.7 |
| 2025-12-31 | 3.0M | -1.8% | 6.69% | 96.5K | 31.3 |
| 2025-12-15 | 3.1M | +5.2% | 6.81% | 171K | 18.0 |
| 2025-11-28 | 2.9M | -0.9% | 6.47% | 188K | 15.6 |
| 2025-11-14 | 3.0M | +23.2% | 6.53% | 410K | 7.2 |
| 2025-10-31 | 2.4M | +8.4% | 5.30% | 286K | 8.4 |
| 2025-10-15 | 2.2M | +0.2% | 4.89% | 148K | 14.9 |
| 2025-09-30 | 2.2M | +1.9% | 4.88% | 143K | 15.5 |
| 2025-09-15 | 2.2M | +2.4% | 4.79% | 177K | 12.3 |
| 2025-08-29 | 2.1M | -4.7% | 4.68% | 94.6K | 22.4 |
| 2025-08-15 | 2.2M | +5.5% | 4.91% | 85.6K | 25.9 |